Evaluation of an optimal luteal phase support protocol in IVF. - Wikidata - awgldk - TriplyDB

Evaluation of an optimal luteal phase support protocol in IVF.

Evaluation of an optimal luteal phase support protocol in IVF.

http://www.wikidata.org/entity/Q34235818

about

IVF and breast cancer: a systematic review and meta-analysis Assessment of the luteal phase in stimulated and substituted cycles.Progesterone vaginal ring for luteal support.Has ART Finally Got a Patient-Friendly Progesterone?Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis.An update of luteal phase support in stimulated IVF cycles.The Effects of Progesterone Therapy on the Gestation Length and Reduction of Neonatal Complications in Patients who had Received Tocolytic Therapy for Acute Phase of Preterm Labor Luteal phase support in in vitro fertilization: meta-analysis of randomized trials.Estradiol supplementation in intracytoplasmic sperm injection cycles with thin endometrium.

P2860

Q28295207-F7962077-52A6-4E67-99A8-E6C645A210C0 Q34608208-D2AF231F-33D8-45E4-80FC-8356F73134E5 Q35126328-EBB7C8C2-25BF-4DA1-9646-77ABA6AC753C Q36083776-C37B8AA6-3162-4CBD-8F5E-1CAB8A3FA966 Q36526902-6F86B775-2C78-49B4-A844-FB0BFD1D86A7 Q36552704-21DED096-8380-4E7E-B127-C882BC623AD4 Q36878307-8290AC34-01EE-403D-891F-2947D5BC823A Q37631995-D8EDBD92-8543-4E1C-B8A2-6A052BB24A66 Q46398886-7A527507-6892-4E11-819C-BA1FC50E9DE2 Q48639955-1FF2723D-0CB7-48AE-AFB3-F0899E2F7B1C

P2860

Evaluation of an optimal luteal phase support protocol in IVF.

http://www.wikidata.org/entity/Q34235818

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Evaluation of an optimal luteal phase support protocol in IVF.

@ast

Evaluation of an optimal luteal phase support protocol in IVF.

@en

Evaluation of an optimal luteal phase support protocol in IVF.

@nl

type

label

Evaluation of an optimal luteal phase support protocol in IVF.

@ast

Evaluation of an optimal luteal phase support protocol in IVF.

@en

Evaluation of an optimal luteal phase support protocol in IVF.

@nl

prefLabel

Evaluation of an optimal luteal phase support protocol in IVF.

@ast

Evaluation of an optimal luteal phase support protocol in IVF.

@en

Evaluation of an optimal luteal phase support protocol in IVF.

@nl

P1433

Q34235818-7B8E1865-415D-45B1-B709-F04ED9603677

P1476

Q34235818-64631E0B-0AC4-4365-935A-1E3CC53ADA93

P2093

Q34235818-132E494B-F2B3-4419-8B2D-94FA0625300B

Q34235818-92F79FA4-2B3B-44CA-9EC4-3FAF93E9CF99

P2860

Q34235818-0B2823DF-B13D-4117-B67E-02BE650A5C82

Q34235818-12B56291-DEB8-4C40-B134-9B4C0FE65660

Q34235818-15C42E36-399F-4391-B9DC-2855D6351163

Q34235818-189B0942-33A4-4975-93E3-E420599BAAC6

Q34235818-1E9FF48A-CDEE-4959-9848-511FC95B10E8

Q34235818-2B425D40-FB2B-4366-B93B-853FB9E5113E

Q34235818-322D88A6-24C4-4300-9BED-CBBCA3AFD3B9

Q34235818-3C49FFEF-9924-4417-919B-0326DE684CEB

Q34235818-4751894D-B5AF-479F-AD16-627AFADB1992

Q34235818-4BA1D042-1754-4DBD-A3E9-924B35232C8F

P304

Q34235818-9E1A2827-50BF-415B-A8A4-8D0D95F97723

P31

Q34235818-296acf27-bedd-4774-981e-2a9a5f9e7bcb

Q34235818-45DA0F6B-9407-4E85-9520-059760C5662E

P356

Q34235818-5D45D0FE-46DE-481C-90F4-478BACC2023F

P433

Q34235818-B0052B37-BA0E-46B0-B2AA-CB5B5DDD89FC

P478

Q34235818-917162F4-7039-4809-81C1-5160BB9B97D7

P577

Q34235818-01110CC8-A647-4A0F-97A6-168AC934454D

P698

Q34235818-C1EDEF20-C9C0-415D-A136-1F14AA6CEB66

P356

J.1600-0412.2001.080005452.X

P1433

Acta Obstetricia et Gynecologica Scandinavica

P1476

Evaluation of an optimal luteal phase support protocol in IVF.

@en

P2093

Diedrich K

http://www.w3.org/2001/XMLSchema#string

Ludwig M

http://www.w3.org/2001/XMLSchema#string

P2860

Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments.

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone.

The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres.

Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.

Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.

GABA physiology: modulation by benzodiazepines and hormones.

The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme.

Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles.

Experience with a novel vaginal progesterone preparation in a donor oocyte program.

P304

452-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-0412.2001.080005452.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11328224

http://www.w3.org/2001/XMLSchema#string